Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug

Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development

Published Date: March 2008

Published By: Kalorama Information

Page Count: 250

Order Code: R566-420

Questions About This Report

E-mail a Colleague

Printable Page

Fax Your Order

Description

Table of Contents

Purchase
by the Section

Search Inside
this Report

Similar
Products

With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells.

For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development. Kalorama analyst Alison Sahoo has built models to determine the best, moderate and worst case scenarios for the three key markets for stem cells:

Stem Cell Therapeutics (Transplantation)
Cord Blood Banking and
Drug development

This report breaks down forecasted revenues and procedure volumes for stem cell technologies for these segments in the following disease areas:

Cardiovascular disease
Lung disease
Arthritis
Incontinence
Osteoporosis
Diabetes
Cancer
Orthopedics
Infertility
Alzheimer’s disease
Burns (severe)
Lupus
Parkinson’s disease
Liver failure
Multiple sclerosis
Critical limb ischemia
Crohn's disease
Sickle cell disease
Multiple myeloma
NH lymphoma
Leukemia

Ths report is the result of exclusive interviews with executives in the stem cell industry, a review of medical and company literature, government databases and publications. As part of this comprehensive analysis of stem cell markets, the following companies were profiled:

Aastrom Biosciences
Advanced Cell Technologies
Brainstorm Cell Therapeutics
Celegene
Cord Blood America
Cord Blood Registry
Cryo-Cell International
ES Cell International
Geron
Harvest Technologies
Invitrogen
Medistem
Neostem
Opexa Therapeutics
Osiris Therapeutics
Plureon
Regenetech
Revivicor
Stem Cell Sciences
StemLifeLine
ThermoGenesis
VetCell Bioscience
ViaCell

License Note: Kalorama Information's listed default price on its information products reflects a single user license only. Purchasing a departmental license (up to 10 users at one location) or a global site license (entire company) permits multiple individuals in the company to benefit from this resource.

Similar Products

• Regenerative Medicines: Bone and Joint Applications

Published Oct 2009 by BCC Research

• Stem Cell Markets

Published Jun 2009 by Trimark Publications

• Growth Factors (Blood And Tissue)

Published Oct 2008 by Global Industry Analysts

• Advances in Replacement Organs and Tissue Engineering (Technical Insights)

Published Sep 2008 by Frost & Sullivan

• Tissue Engineering and Cell Transplantation: Technologies, Opportunities, and Evolving Markets in the U.S.

Published Jul 2007 by Medtech Insight

• Stem Cell - Analysis and Market Forecasts, 2006-2016